Syneron Bio
Develops intelligent platform-driven macrocyclic peptide drug discovery
$150MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops intelligent platform-driven macrocyclic peptide drug discovery
Pitching AstraZeneca? Send the deck from a free RoundOS data room and see which pages they read.